Dual role of B7‐H6 as a novel prognostic marker in hepatocellular carcinoma

Positive staining of the immunoligand B7-H6 in abnormal/transformed keratinocytes consistently accompanies the progression of cervical cancer

(2020) Gloria Yareli Gutierrez-Silerio et al.   BMC IMMUNOLOGY

The prognostic value of B7-H6 in esophageal squamous cell carcinoma

(2019) Huan Zhou et al.   Scientific Reports

Expression of B7-H6 expression in human hepatocellular carcinoma and its clinical significance

(2018) Lujun Chen et al.   Cancer Cell International

Deficient natural killer cell NKp30-mediated function and altered NCR3 splice variants in hepatocellular carcinoma

(2018) Stefania Mantovani et al.   HEPATOLOGY

Clinical significance of novel costimulatory molecule B7-H6 in human breast cancer

(2017) Jing Sun et al.   Oncology Letters

High expression of B7-H6 in human glioma tissues promotes tumor progression

(2017) Tianwei Jiang et al.   Oncotarget

Impact of natural killer cells on chronic hepatitis C and hepatocellular carcinoma

(2016) Tomohide Tatsumi et al.   HEPATOLOGY RESEARCH

Innate Immune Recognition of Cancer

(2015) Seng-Ryong Woo et al.   Annual Review of Immunology

Cancer statistics, 2015

(2015) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Immunotherapy in hepatocellular carcinoma: Primed to make a difference?

(2015) James J. Harding et al.   CANCER

B7H6-specific chimeric antigen receptors lead to tumor elimination and host antitumor immunity

(2015) M-R Wu et al.   GENE THERAPY

Tumor Therapeutics Work as Stress Inducers to Enhance Tumor Sensitivity to Natural Killer (NK) Cell Cytolysis by Up-regulating NKp30 Ligand B7-H6

(2015) Guoshuai Cao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients

(2015) Michaela Semeraro et al.   Science Translational Medicine

Natural killer cell mediated immunosurveillance of pediatric neuroblastoma

(2015) Michaela Semeraro et al.   OncoImmunology

Metalloprotease-Mediated Tumor Cell Shedding of B7-H6, the Ligand of the Natural Killer Cell-Activating Receptor NKp30

(2014) E. Schlecker et al.   CANCER RESEARCH

Coordinated Regulation of NK Receptor Expression in the Maturing Human Immune System

(2014) Dara M. Strauss-Albee et al.   JOURNAL OF IMMUNOLOGY

Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions

(2013) J. Matta et al.   BLOOD

Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells

(2013) N. Fiegler et al.   BLOOD

B7-H6 Protein Expression has no Prognostic Significance in Human Gastric Carcinoma

(2013) Xiao-Juan Chen et al.   PATHOLOGY & ONCOLOGY RESEARCH

Dendritic Cell Editing by Activated Natural Killer Cells Results in a More Protective Cancer-Specific Immune Response

(2012) Barbara Morandi et al.   PLoS One

B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors

(2011) Tomonori Kaifu et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6

(2011) Yili Li et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Crystal structure of human natural cytotoxicity receptor NKp30 and identification of its ligand binding site

(2011) M. G. Joyce et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

(2009) Cameron S. Brandt et al.   JOURNAL OF EXPERIMENTAL MEDICINE